MDCXW
Medicus Pharma Ltd. WarrantNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
-0.65
52W High
$2.50
52W Low
$0.31
50-Day MA
$2.50
200-Day MA
$2.50
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Medicus Pharma Ltd. Warrant
Medicus Pharma Ltd. (MDCXW) is an emerging leader in the pharmaceutical industry dedicated to the development and commercialization of advanced therapies addressing critical healthcare needs. Leveraging a robust pipeline powered by innovative research methodologies and compliance with stringent regulatory standards, the company is strategically positioned to respond to the dynamic landscape of medical demands. Medicus Pharma is committed to enhancing patient outcomes and delivering sustainable long-term value for investors through its pioneering healthcare solutions.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | -2865.00% |
| Return on Assets | -278.10% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.03 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $50.34M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
—
HV 20-Day
—
HV 30-Day
—
HV 60-Day
—
HV Rank
—
Data last updated: 7/9/2026